To index or not to index? That is the question

Is buying an index fund the right approach for your portfolio?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Indexing, or passive investing, is all the rage at the moment. According to research from Bank of America since 2002 over $1.4trn of assets have found their way into passive ETFs. Meanwhile, investors have been dumping actively managed funds. 

Year-to-date $260bn has flowed out of US long-only equity mutual funds, 3.9% of industry assets under management. At this rate, it will only take 19 years for US investors to dump all of their holdings in actively managed funds. Analysts at Deutsche Bank have echoed this view. They believe that within five years the size of the so-called passive ETF market could grow to $6.2trn, up from $2.2trn today. 

But should you join this trend? 

Pros and cons 

There are a number of arguments both for and against the passive indexing movement. 

Firstly, in the ‘pro’ camp, passive funds usually have lower fees than their active counterparts. Over the long term, the extra 0.5%-1% in performance gained by lower fees can really add up. Secondly, passive funds have a record of outperforming active fund managers because they’re tracking an index and there’s no risk of making a stock picking mistake — if the index does well, the index fund should replicate its performance with the only negative drag being fees. 

However, indexing has its drawbacks as well. For a start, buying the whole index may not be suitable for every investor as it confines you to averages: an average performance and average yield.

Granted, an index portfolio will make sure your returns are matched to the index you’re tracking, but is this really the best solution for you? 

An income-seeking investor might prefer to buy a portfolio of dividend champions such as Shell, GlaxoSmithKline and BAE Systems alongside an index fund. Meanwhile, a growth investor with a longer investment horizon might consider buying an actively managed fund that targets growth stocks with a few select single stock ideas added to the portfolio to give it a boost. 

Moreover, fees are a problem with index funds. Indeed, most brokers charge an account management fee, so why should you have to pay a fee to the fund managers running an index fund when a portfolio of blue chips may produce the same, if not better, result?

Depends on your circumstances 

Ultimately, whether or not you should follow the trend of indexing depends on your circumstances.

If you’re a beginner investor who can’t wait to dive into the market, it may be best to buy an index fund and learn the ropes before plunging into individual stocks. If you have some experience investing, using an index fund alongside some select stock picks may help boost your long-term returns. All in all, index funds can be helpful for some, but they’re not a blanket solution for all investors. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns shares of GlaxoSmithKline and Royal Dutch Shell B. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »